The 2017 Hormone Therapy Position Statement of The North American Menopause Society

Council for International Organizations of Medical Sciences (CIOMS).^3.

Authors and Disclosures

This position statement was developed by The North American Menopause Society 2017 Hormone Therapy Position Statement Advisory Panel consisting of representatives of the NAMS Board of Trustees and other experts in women's health: JoAnn V. Pinkerton, MD, NCMP, Chair; Dr. Fernando Sánchez Aguirre; Jennifer Blake, MD, MSC, FRCSC; Felicia Cosman, MD; Howard Hodis, MD; Susan Hoffstetter, PhD, WHNP-BC, FAANP; Andrew M. Kaunitz, MD, FACOG, NCMP; Sheryl A. Kingsberg, PhD; Pauline M. Maki, PhD; JoAnn E. Manson, MD, DrPH, NCMP; Polly Marchbanks, PhD, MSN; Michael R. McClung, MD; Lila E. Nachtigall, MD, NCMP; Lawrence M. Nelson, MD; Diane Todd Pace, PhD, APRN, FNP-BC, NCMP, FAANP; Robert L. Reid, MD; Phillip M. Sarrel, MD; Jan L. Shifren, MD, NCMP; Cynthia A. Stuenkel, MD, NCMP; and Wulf H. Utian, MD, PhD, DSc (Med). The Board of Trustees conducted an independent review and revision and approved the position statement.

This position statement was made possible by donations to the NAMS Education & Research Fund. There was no commercial support.

Address correspondence to
The North American Menopause Society; 30100 Chagrin Blvd., Suite 210; Pepper Pike, OH 44124. E-mail: info@menopause.org. Website: www.menopause.org.

Financial disclosure/Conflicts of interest
For the Advisory Panel, Dr. Aguirre, Dr. Blake, Dr. Hodis, Dr. Hofstetter, Dr. Maki, Dr. Manson, Dr. Marchbanks, Dr. Nelson, Dr. Sarrel, and Dr. Stuenkel each report no financial relationships. Dr. Cosman reports Advisor for Merck and Radius; Consultant for Tarsa; Speaker/Advisor/Investigator for Amgen and Eli Lilly. Dr. Kaunitz reports Advisory Board for Mithra; Author for UpTo-Date; Consultant for Allergan and Shionogi; Investigator for Radius and TherapeuticsMD; Investigator/Advisory Board for Bayer. Dr. Kingsberg reports Consultant/Advisory Board for AMAG, Endoceutics, Novo Nordisk, Pfizer, Shionogi, Strategic Scientific Solutions, and TherapeuticsMD. Dr. McClung reports Consultant for Merck and Radius; Consultant/Speaker for Amgen. Dr. Nachtigall reports Educational Production for Pfizer. Dr. Pace reports Advisory Board for Hologic; Advisory Board/Expert Panel for Allergan; Speaker/Advisory Board for Pfizer. Dr. Pinkerton reports Consultant for Pfizer, fee paid to institution; Investigator for TherapeuticsMD, fee paid to institution. Dr. Reid reports Advisory Board for Allergan, Bayer, Mithra, and Pfizer. Dr. Shifren reports Consultant for New England Research Institutes. Dr. Utian reports Consultant/Advisory Board for Endo-ceutics, Mithra, Pharmavite, and PulseNMore.
For additional contributors, Ms. Develen and Ms. Method report no financial relationships.